Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Trial of Aeroquin Versus Tobramycin Inhalation Solution (TIS) in Cystic Fibrosis (CF) Patients (TIS)

This study has been completed.
Information provided by (Responsible Party):
Forest Laboratories Identifier:
First received: January 3, 2011
Last updated: July 11, 2013
Last verified: July 2013
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: June 2013
  Primary Completion Date: October 2012 (Final data collection date for primary outcome measure)